The store will not work correctly when cookies are disabled.
1-(Methyl)-2-(methyl)-3-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)imidazolium chloride
ID: ALA3758313
PubChem CID: 127027682
Max Phase: Preclinical
Molecular Formula: C12H14ClN5
Molecular Weight: 228.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1n(C)cc[n+]1Cn1nnc2ccccc21.[Cl-]
Standard InChI: InChI=1S/C12H14N5.ClH/c1-10-15(2)7-8-16(10)9-17-12-6-4-3-5-11(12)13-14-17;/h3-8H,9H2,1-2H3;1H/q+1;/p-1
Standard InChI Key: ZTPYEOWNZHMMNG-UHFFFAOYSA-M
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
9.2451 2.0420 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2449 4.2986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7388 1.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0412 2.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7359 4.1352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5429 5.0233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6433 5.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
2 6 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
8 12 1 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
12 13 2 0
7 8 1 0
3 7 1 0
6 17 1 0
2 18 1 0
M CHG 2 1 -1 3 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 228.28 | Molecular Weight (Monoisotopic): 228.1244 | AlogP: 0.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 39.52 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.17 | CX LogP: -2.47 | CX LogD: -2.47 |
Aromatic Rings: 3 | Heavy Atoms: 17 | QED Weighted: 0.61 | Np Likeness Score: -1.52 |
References
1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855] [10.1016/j.bmc.2016.02.012] |